References
- Ochoa-Azze RF. Cross-protection induced by VA-MENGOC-BC(R) vaccine. Human vaccines & immunotherapeutics. 2018; In press.
- Harder T, Koch J, Wichmann O, Hellenbrand W. Predicted vs observed effectiveness of outer membrane vesicle (OMV) vaccines against meningococcal serogroup B disease: Systematic review. J. Infect. 2017;75(2):81–94. doi:10.1016/j.jinf.2017.05.001. PMID:28487177.
- Holst J, Oster P, Arnold R, Tatley M, Næss L, Aaberge I, Galloway Y, McNicholas A, O'Hallahan J, Rosenqvist E, et al. Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): Lessons from past programs and implications for the future. Human vaccines & immunotherapeutics. 2013;9(6):1241–53. doi:10.4161/hv.24129.